2m 2m 2m 2m 2m 2m 2m
ROCKWELL MED (RMTI)
NASDAQ
$8.12+$0.16 (+2.06%)
Price as of Sep 11, 2026 7:57 PM EDT- $32.1MMarket Cap
- -50.86%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
ROCKWELL MED (RMTI)
$8.12+$0.16 (+2.06%)
RMTI | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $7.96 | ||
Change | -$0.08 (-1.00%) | ||
Open | $7.87 | ||
High | $8.34 | ||
Low | $7.87 | ||
Previous Close | $8.04 | ||
Volume | 42,754 | ||
30-Day Average Volume | 28,542 | ||
1-Week Change | -0.31% | ||
1-Month Change | 12.43% | ||
1-Year Change | -50.86% | ||
3-Year Change | -64.30% | ||
5-Year Change | -88.80% | ||
Fundamentals | |||
Shares Outstanding | 4.0M | ||
Total Assets | $56.5M | ||
Market Cap | $32.1M | ||
Enterprise Value | $30.6M | ||
Period: QTR TTM FY | |||
Revenue | $17.8M | ||
Net Income | -$1.2M | ||
Free Cash Flow | $1.5M | ||
EBIT | -$1.2M | ||
EBITDA | -$680,000.00 | ||
Net Working Capital | $25.2M | ||
EPS | -$3.40 | ||
Enterprise Value/EBITDA | -45 | ||
Enterprise Value/Revenue | 2 | ||
P/B | 1 | ||
P/E | -2 | ||
PEG | 0 | ||
Price/Free Cash Flow | 22 | ||
Price/Operating Cash Flow | 15 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 07/01/2026 | ||
Earnings & Revenue